Research
-
COVID-associated delays for elective services studied
This spring in the U.S., there were widespread delays in elective health care procedures and screenings. Read MoreDec 17, 2020
-
Immune and circulatory systems are functionally integrated in all insects, Vanderbilt biologists demonstrate
A new study shows that insect immune and circulatory systems cooperate to fight infection, similar to those in mammals. Read MoreDec 16, 2020
-
Analysis of ancient teeth reveal clues about how sociopolitical systems grow
Isotope analysis of ancient Peruvian teeth gives anthropologists a clearer image of how cooperating societies function. Read MoreDec 15, 2020
-
Computer science team wins global contest with AI model that translates English to code
IBM will use a Vanderbilt model as the end-user scripting assistant in its open-source Command Line AI Project. Read MoreDec 14, 2020
-
Researchers develop unique process for producing light-matter mixture
Discovery provides insight for developing next generation optoelectronic and infrared devices In groundbreaking new research, an international team that includes a Vanderbilt engineer has developed a unique process for producing a quantum state that is part light and part matter. Read MoreDec 7, 2020
-
Engineering professor Ndukaife wins award in Rising Stars of Light global competition
Justus Ndukaife, assistant professor of electrical engineering, spent 20 minutes describing his optical nanotweezers to a panel of five distinguished professors from the United States, Australia, and China during a live online competition—Rising Stars of Light—that has drawn 260,000 viewers worldwide. Read MoreNov 30, 2020
-
Hot spots identified for colorectal cancer mortality rates among young women
Women diagnosed with early-onset colorectal cancer have a greater risk of dying from the disease depending upon their county of residence, according to a study published in Clinical and Translational Gastroenterology. Read MoreNov 23, 2020
-
Why does COVID-19 seem to spare children? Vanderbilt University Medical Center study offers an answer
Researchers at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. Read MoreNov 18, 2020
-
New drug for metastatic colorectal cancer enters phase 3 trial
A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center. Read MoreNov 18, 2020
-
Younger parents less likely to vaccinate their children and themselves against COVID-19
Younger parents were much less likely than older parents to say they planned to vaccinate their children and themselves against COVID-19. Read MoreNov 16, 2020
-
Imaging “biomarker” for Alzheimer’s disease progression
Changes in connectivity in the brain’s white matter may be a novel neuroimaging biomarker for assessing Alzheimer’s disease progression. Read MoreNov 16, 2020
-
New therapeutic target for lung cancer
Vanderbilt researchers have identified a new molecular partner — and potential therapeutic target — in a signaling axis that drives lung cancer. Read MoreNov 12, 2020
-
Breast cancer treatment in older women
A new study from Vanderbilt epidemiologists suggests that it’s time to reconsider clinical practice guidelines for the treatment of early-stage breast cancer in older women. Read MoreNov 12, 2020
-
Study underscores importance of personalized medicine in kidney cancer
A new study sheds light on how molecular subsets within the tumors of kidney cancer patients determine treatment outcomes and underscores the importance of personalized medicine in making therapy decisions. Read MoreNov 10, 2020
-
Hydroxychloroquine does not help patients hospitalized with COVID-19: Study
Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes. Read MoreNov 9, 2020
-
New research documents how COVID-19 multiplies stress and trauma for people with disabilities
A November article published in Rehabilitation Psychology reviews research on disabilities and COVID-19 to help rehabilitation psychologists mitigate the effects of the added stress of the pandemic. In addition, the work addresses how systemic discrimination against people with disabilities intersects with other forms of inequity. Read MoreNov 4, 2020
-
VUMC begins study of second COVID-19 vaccine
Vanderbilt University Medical Center has begun recruiting up to 250 participants for a Phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. Read MoreNov 2, 2020
-
Jerri Rook is awarded the Alzheimer’s Drug Discovery Foundation’s prestigious Melvin R. Goodes prize
Behavioral and systems neuropharmacologist Jerri Rook is recognized by the Alzheimer’s Drug Discovery Foundation with the Goodes Prize to continue her work in Alzheimer’s disease research. Read MoreNov 2, 2020
-
Vanderbilt trans-institutional team shows how next-gen wearable sensor algorithms powered by machine learning could be key to preventing injuries that sideline runners
An interdisciplinary team of researchers led by Karl Zelik explores how wearable sensor technology can monitor bone stress in runners, developing a new multi-sensor algorithm that could save runners from months of pain and recovery time. Read MoreOct 28, 2020
-
Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment
Jacek Hawiger’s anti-inflammatory peptide therapy, licensed by Amytrx and now in clinical trials, has the potential to safely and effectively treat a multitude of inflammatory and metabolic diseases. Read MoreOct 27, 2020